Introduction
Eukaryotic cells are divided into membrane-bound compartments where most cellular functions are carried out. Trafficking among the compartments of the biosynthetic and the endocytic pathways is mediated by vesicular carriers that pinch off from the donor membrane and deliver their cargo to the acceptor membrane. To guarantee the vectoriality intrinsic to the continuous fission and fusion of lipid bilayers in vesicular trafficking, specificity of the molecular interactions is required at both the sorting and targeting stages. Recently, some of the protein-protein interactions involved in transport vesicle docking and fusion have been identified by combining results from several independent approaches, including studies on the biochemistry of mammalian intra-Golgi transport, the genetics of the yeast secretory pathway, and the biochemistry of neurotransmitter release (reviewed by Pryer et al., 1992; Bennett and Scheller, 1994; Rothman, 1994) . Convergence of information from these sources has revealed fundamental similarities in the mechanisms of vesicular delivery between different pathways and a high degree of evolutionary conservation among distantly related systems.
Fusion of transport vesicles with their respective target membranes has been shown to depend on soluble adapter molecules, the N-ethylmaleimide (NEM)-sensitive factor (NSF) and the soluble NSF attachment proteins (SNAPS) (reviewed by Rothman, 1994) . NSF and SNAPS function as general components of a conserved membrane docking and fusion apparatus, while compartmental specificity is provided by the SNAP membrane receptors (SNARES) (Slillner et al., 1993) . Recent findings have led to the hypothesis that the specificity of vesicle targeting is achieved by binding of a SNARE on the vesicle membrane (v-SNARE) with its cognate SNARE on the target membrane (t-SNARE). This complex then binds SNAPS, which in turn attach NSF to facilitate membrane fusion in a process involving ATP hydrolysis by NSF (Rothman and Warren, 1994) . A further layer of specificity is added by the family of Rab proteins, which regulate vesicular transport by their GTPase activities (Zerial and Stenmark, 1993) .
We have here examined the involvement of the Rab-NSF-SNAP-SNARE machinery in exocytotic vesicular transport in epithelial Madin-Darbycanine kidney(MDCK) cells. Polarized epithelial cells form continuous sheets separating the outside and inside world of multicellular organisms. To carry out its vectorial functions, each cell develops and maintains a specialized cell surface architecture in which the apical plasma membrane of the cell faces the external milieu and the basolateral cell surface is in contact with the underlying extracellular matrix and the blood supply (Simons and Fuller, 1985) . The membrane asymmetry is generated by polarized protein and lipid delivery to the cell surfaces. The sorting site varies among epithelial cell types (Rodriguez-Boulan and Powell, 1992) . In MDCK cells, apically and basolaterally destined proteins move together from their site of synthesis in the endoplasmic reticulum (ER) to the trans-Golgi network (TGN) (Griffiths and Simons, 1986; Hughson et al., 1988) where they are incorporated into two separate vesicle populations fusing specifically with the apical and basolateral plasma membranes (Wandinger-Ness et al., 1990) . To characterize functionally the molecular machinery involved in the process of polarized sorting and targeting, we have designed an in vitro system in which multiple transport steps, both nonpolarized protein delivery and polarized protein transport, can be reconstituted in MDCK cells (Kobayashi et al., 1992; Pimplikar and Simons, 1993; Pimplikar et al., 1994) . We use the bacterial toxin streptolysin 0 (SLO) to introduce pores selectively in either the apical or the basolateral surface of MDCK cells, and we monitor the delivery of a viral marker protein from the ER to the Golgi complex or from the TGN to the intact cell surface. Using this permeabilized cell system, we have assayed the known general components of the docking and fusion machinery by testing the effects of anti-NSF monoclonal antibodies and purified a-SNAP protein. We studied the possible requirement for SNARES by using tetanus toxin (TeTx) and botulinum neurotoxin serotype F (BoNT F) and the involvement of Rab proteins by using Flab-GDP dissociation inhibitor (Rab-GDI). We demonstrate here that NSF and SNAP are involved in vesicular transport from the ER to the Golgi complex as has been previously reported for other cell types (Beckers et al., 1989; Graham and Emr, 1991; Griff et al., 1992) . Weshow that the Rab-NSF-SNAP-SNARE mechanism operates in vesicular transport from the TGN to the basolateral plasma membrane, and we provide evidence that the machinery used for delivery of cargo to the apical plasma membrane differs from the two other pathways.
Results

Background
The permeabilized cell system we use (Pimplikar et al., 1994 ) is based on filter-grown MDCK cells that are capable of sorting viral glycoproteins in the TGN and delivering them in a polarized fashion to the two plasma membrane domains (Rodriguez-Boulan and Pendergast, 1980; Fuller et al., 1985) . Influenza virus hemagglutinin (HA) serves as our apical marker, whereas vesicular stomatitis virus spike glycoprotein (VSV G) is used as the basolateral marker. When measuring transport from the TGN to the cell surface, the marker protein is pulse labeled and accumulated in the TGN using a 20% block. The cells are then permeabilized with SLO at 20°Cfrom either the apical (basolateral assay) side or basolateral (apical assay) side. The endogenous cytosol is depleted at 20°C, and transport is reconstituted at 37% in the presence of exogenously added cytosol supplemented with an ATP-regenerating system. Basolateral delivery is measured by surface immunoprecipitation of VSV G whereas apical transport is quantitated by the trypsin sensitivity of surface HA. When measuring transport from the ER to the Golgi complex, the marker protein, either HA or VSV G, is pulse labeled, and SLO permeabilization is carried out for only 2 min at 37OC so that the marker protein remains in the ER. Following cytosol depletion at 4°C transport to the Golgi is dependent on exogenously added cytosol, temperature, and ATP and is measured by the endoglycosidase H (endo H) sensitivity of the marker proteins.
In the initial experiments, we tested the sensitivity of the three transport processes to NEM. The conditions reported in other systems to inhibit transport (1 mM NEM, 15 min, 0%) (Glick and Rothman, 1987) were inhibitory both in ER-to-Golgi transport and in the two polarized pathways (data not shown). These observations are consistent with the involvement of NSF in these transport processes, but do not exclude the possibility that other proteins sensitive to the alkylation by NEM are responsible for the inhibition, as has been shown for transport between the endosomal compartment and the TGN (Goda and Pfeffer, 1991) and for endosomal vesicle fusion (Rodriguez et al., 1994) . In our experiments, NEM was applied to the cells after SLO permeabilization and was quenched with dithiothreitol prior to transport. However, NEM treatment of exogenous cytosol did not inhibit transport in any of the pathways. This suggests that the exogenous cytosol does not supply rate-limiting amounts of NEM-sensitive proteins. Based on this result, specific immunodepletion of NSF from exogenous cytosol would be unlikely to have any effect on the transport assays.
Next we tested the efficiency of NSF removal from MDCK cells under our cytosol depletion conditions by Western blot analysis of intact and cytosol-depleted cells with anti-NSF antibodies. We found that anti-NSF immunoreactivity in the cells was not significantly decreased by cytosol depletion, suggesting that in our transport system the freely diffusible cytosolic NSF pool is small (data not shown). NSF probably remains membrane bound as the conditions are not optimal for NSF extraction (Clary and Rothman, 1992; Wilson et al., 1992) and the system may be primed in such a way that NEM-inactivated NSF added in the exogenous cytosol cannot replace the bound molecules. It is not known at exactly what stage of transport NSF is attached to membranes. It has been suggested that rather than being a factor that binds the membrane at the fusion stage, NSF could be incorporated already into the forming vesicles (Wattenberg et al., 1992; Sumida et al., 1994) .
Anti-NSF Antibodies
Inhibit ER-to-Golgi Transport of HA and Basolateral Transport of VSV G, but Have No Effect on Apical Transport of HA To address specifically the functional involvement of NSF in exocytotic membrane trafficking in MDCK cells, we tested the effect of adding monoclonal anti-NSF antibodies (Tagaya et al., 1993) to SLO-permeabilized cells, and we measured either transport of HA from the ER to the Golgi or from the TGN to the apical surface or delivery of VSV G from the TGN to the basolateral surface. These antibodies have been shown to be inhibitory in thecell-free intra-Golgi transport assay (Tagaya et al., 1993; Whiteheart et al., 1994) . Two of them, 2E5 and 6E6, recognize an epitope in the ATPase domain of NSF, while one, 2C8, reacts with the N-terminal domain, which might have a regulatory function, as 2C8 stimulates the ATPase activity of NSF (Whiteheart et al., 1994) .
We found that all three antibodies significantly inhibited HA transport to the Golgi (about 40-600~) (Figure 1 ). This agrees well with the known involvement of NSF in this transport step and with the reported inhibitory efficiencies of the antibodies in intra-Golgi transport. When the same antibodies with identical concentrations were tested in the polarized transport pathways, basolateral delivery of VSV G from theTGN wasclearly inhibited with all three antibodies and to about the same extent as ER-to-Golgi transport of HA (Figure 1 ). Doubling the antibody concentrations did not result in further inhibition (data not shown). Specificity was confirmed by overcoming the inhibition with equimolar concentration of purified NSF in both basolateral ( Figure  1 ) and ER-to-Golgi (data not shown) transport. However, when the antibodies were added to the apical transport assay, we observed no effect on the amount of HA transported from the TGN to the apical surface with any of the three antibodies (Figure 1 ). The addition of antibodies at The anti-NSF monoclonal antibodies 2E5, 2C6. 6E6, or 2E5 together with purified NSF protein (2E5 plus NSF) were added to ER-to-Golgi (E-G), basolateral (BL), or apical (AP) transport assays as described in Experimental
Procedures.
The endo H resistance of HA and the surface delivery of VSV G or HA were quantitated as detailed in Experimental Procedures.
The values are expressed as 100% being the amount of transport dependent on exogenously added cytosol; e.g., the percentage of ER-to-Golgi transport with 2C6 was calculated from theprimarydata(arbitraryunitsderivedfromquantitationofoneexperiment) of transport in the presence of exogenous cytosol at 43.60 (lOO%), transport in the absence of exogenous cytosol at 12.54 (0%) and transport in the presence of exogenous cytosol and 2C6 at 29.73 (55%). For basolateral transport, the corresponding values are 12.35 (100%) 6.03 (O%), and 9.56 (56%); for apical transport, 54.67 (100%) 22.61 (0%) and 57.75 (110%).
respectively.
The final values are means * SEMs for each experimental condition tested at least three times with duplicate filters.
twice the concentration was also without effect in the apical transport assay (data not shown).
u-SNAP Protein Stimulates ER-to-Golgi Transport of HA and Basolateral
Transport of VSV G without Affecting Apical Transport of HA Intra-Golgi transport can be stimulated by the addition of SNAPS, of which a-SNAP is more potent than y or f3 in increasing transport (Clary and Rothman, 1990) . Analogously, if a-SNAP were a rate-limiting factor in our transport system, adding an excess of the protein should stimulate transport. Again, we used ER-to-Golgi transport of HA as our starting point and standardized the amount of a-SNAP required to produce an effect in this assay. Starting from 100 nM a-SNAP concentrations in the exogenous cytosol, increasing amounts of HA acquired endo H resistance. This stimulation of transport to the Golgi became more pronounced when a-SNAP concentrations were raised further and maximal stimulation (about 150% transport) was obtained with concentrations ranging from 2 PM to 5 uM ( Figure 2 ). With still higher concentrations, transport started to be inhibited, having reached the unstimulated level at 10 uM and being strongly inhibited (up to 50%) by 20 PM a-SNAP concentration (data not shown). About the same degree of stimulation of HA transport to the Golgi was observed already after short transport times (lo-20 min instead of the usual 50 min), although the abso- lute amount of transported marker was of course respectively smaller (data not shown). We chose two clearly stimulatory concentrations of a-SNAP, 2 pM and 5 PM, to test systematically their effects in the polarized transport assays. We found that basolateral transport of VSV G was increased with both concentrations to the same degree as ER-to-Golgi transport of HA ( Figure 3 ). This is in accordance with the observed inhibition of these two transport processes by anti-NSF antibodies. Apical transport of HA, however, remained insensitive to both a-SNAP concentrations ( Figure 3 ). We also used higher concentrations of a-SNAP to test whether the sensitivity of apical transport to a-SNAP addition would be lower than in the two other pathways. A concentration of 10 uM a-SNAP was without any effect, and a concentration of 20 FM proved to be inhibitory, as had been observed for ER-to-Golgi transport of HA (data not shown).
Clostridial
Neurotoxins Inhibit TGN-to-Basolateral Transport of VSV G, but Have No Effect on Apical Transport of HA Based on the results obtained with anti-NSF antibodies and a-SNAP protein, it seemed likely that the NSF-SNAP-SNARE system would operate in the transport from the TGN to the basolateral surface, but that apical transport would not rely on the same machinery as basolateral transport. After the recent findings that clostridial neurotoxins exert their inhibitory function on membrane trafficking by specifically cleaving SNARES (Schiavo et al., 1992; Blasi et al., 1993a Blasi et al., , 1993b , these toxins have provided a new tool to address the role of SNARES in a given vesicular transport step. We therefore tested the effects of both TeTx and BoNT F in the polarized transport pathways. TeTx is known to cleave the neuronal V-SNARE vesicleassociated membrane protein 2 (VAMP-2), but not VAMP-l in vivo, whereas both neuronal VAMPS serve as substrates for BoNT F in vivo (Schiavo et al., 1992 (Schiavo et al., , 1993 . Provided that the v-or t-SNARE needed for basolateral vesicle docking and fusion can be cleaved by the toxins, basolateral Quantitation is as in Figure 1 , and the values represent means f SEMs of three experiments performed with duplicate filters.
transport should be inhibited. On the other hand, if apical transport were inhibited, this would provide a clear argument for a SNARE-based docking and fusion mechanism also for the apically destined vesicles, TeTx experiments in SLO-permeabilized CHO cells (Galli et al., 1994) have shown that the toxin concentrations needed to cleave cellubrevin in living cells are significantly higher than in isolated membrane fractions. We first established the TeTx and BoNT F concentrations needed for efficient cleavage of an MDCK cell VAMP homolog within the time and temperature frame of our transport assays. Since nonneuronal cells lack the surface receptors needed for toxin internalization, the toxins would gain access to the intracellular substrates only through the SLO pores and should already preferentially cleave the SNARES before transport at 37°C was allowed, i.e., during cytosol depletion (20°C for 30 min). When SLO and the toxin were added apically, a VAMP homolog was completely cleaved within 30 min at 20°C by using 500 nM TeTx or 250 nM BoNT F, as judged by Western blotting of MDCK cell lysates with an anti-VAMP-2 antibody (Figure 4 ). When the toxins were added basolaterally, complete cleavage required an additional 5-10 min incubation at 37OC because of slower diffusion through the filter support (Figure 4 ). To quantitate how much apical transport had already occurred during this time and how much would therefore be insensitive to the toxins, we analyzed the kinetics of transport in the in vitro system. The reconstitution of apical transport after cytosol depletion is considerably slower than basolateral transport so that within the first 15 min at 37OC, less than 20% of apical transport has occurred, in contrast with -35% of basolateral transport ( Figure 5 ). This is probably largely attributable to the filter support retarding cytosol entry into the cells. However, because of the slow initiation of apical transport, about 90% of it could potentially be modified by the toxins. SLO was bound to the cell surface after accumulating the viral marker protein in the TGN. After that, either pores were formed and cytosol was depleted at 20% followed by reconstitution of transport at 37OC with exogenous cytosol and an ATP-regenerating system (closed circles and squares), or pore formation and transport were initiated simultaneously at 37% in the presence of an ATP-regenerating system and buffer (open circles and squares).
Cells were incubated at 37% for the indicated times, and surface arrival of HA (circles) or VSV G (squares) was quantitated.
When cytosol was depleted, the data are expressed as cytosoldependent transport after 50 min incubation at 37% being 100%. When cytosol was not depleted, the values are presentedas temperature-dependenttransportafter50min incubation at 37OC being 100%. Rab-GDI was added to cells permeabilized apically or basolaterally and incubated as detailed in Experimental Procedures.
Cell lysates were analyzed by Western blotting with anti-Rab5 antibody, and the amount of membrane-bound Rab5 was quantitated by densitometry.
Values are the average of duplicate measurements.
When TeTx was added at 500 nM concentration to the transport assays, the inhibition of basolateral transport of VSV G was reproducibly about 400/o, whereas apical transport of HA was not affected ( Figure 6A ). BoNT F used at a concentration of 250 nM produced 50% inhibition of basolateral transport, while apical transport remained unaffected ( Figure 6B ). Since the SNARE cleavage with these toxin concentrations was very rapid at 3T°C, we also tested whether the toxins interfered with transport in cells not depleted of cytosol, in which a shift to 37% will result in rapid SLO pore formation and entry of the toxin simultaneously with the initiation of transport. Even though both apical and basolateral transport demonstrated significantly faster kinetics in this system (see Figure 5 ), only 40% of both apical and basolateral transport had occurred by 10 min at 37% (at which time complete cleavage of the VAMP homolog was achieved). When performing the assays in SLO-permeabilized cells not depleted of cytosol, we observed 50% inhibition of basolateral transport of VSV G in the presence of 500 nM TeTx, but again saw no effect on apical transport of HA ( Figure 6C ). Tosummarize, we found bothTeTxand BoNTFtoinhibit basolateral VSV G transport, while the apical HA transport remained completely unaffected in conditions in which both toxins were shown to have cleaved a VAMP-immunoreactive protein in MDCK cells.
Flab-GDI Inhibits Basolateral
Transport of VSV G, but Has No Effect on Apical Transport of HA Recent evidence suggests that Rab proteins function in vesicular fusion by regulating the interactions among SNARES (Lian et al., 1994; Sagaard et al., 1994) . Rab-GDI, which releases Rab proteins from membranes, has been shown to inhibit mammalian ER-to-Golgi and intercisternal Golgi transport (Peter et al., 1994; Elazar et al., 1994) . We therefore tested the effect of Rab-GDI apically and basolaterally. We found Rab-GDI to inhibit significantly basolateral VSV G transport at concentrations known effectively to remove Rabs from permeabilized MDCK cells (Ullrich et al., 1993) . We obtained -50% inhibition using 2 PM Rab-GDI, and with 5 uM Flab-GDI, transport was almost completely inhibited. When added to the apical transport assay, both concentrations of Rab-GDI failed to produce significant reduction in HA surface delivery ( Figure 7A ). To ascertain that the differential effects of Rab-GDI were not due to less efficient extraction of Rabs in the apical transport assay, we measured the Rab-GDI removal of Rab5, which is associated with both the apical and basolateral plasma membrane and underlying structures (Bucci et al., 1994) . Rab5 was found to be released from membranes with equal efficiency (80-90% removal at 5 uM Rab-GDI) independent of whether it was added apically or basolaterally ( Figure 7B ).
Discussion
The apical and basolateral membrane trafficking pathways in MDCK cells are known to exhibit fundamental differences. The sorting of cargo to the apically or basolaterally destined carriers is based on the recognition of different signals (Mostov et al., 1992; Matter et al., 1993) . The interactions responsible for the sorting events seem to take place on opposite sides of the TGN membrane, and these are known to include lipids as well because glycosphingolipids (and GPI-anchored proteins) are preferentially targeted to the apical membrane (Simons, 1995) . The cargo proteins and lipids are assumed to interact with each other through linker proteins to form the patch in the TGN that turns into the apical vesicle. The basolateral proteins, on the other hand, carry sorting signals in their cytosolic tails that are recognized by adaptor proteins for inclusion into the basolateral vesicles (Matter and Mellman, 1994) . Not only do the apical and basolateral vesicles differ in their contents of cargo, but the vesicular proteins also show differences. These molecules are candidates for involvement in vesicle formation or delivery. We have identified several vesicular membrane proteins in a complex with the apically targeted influenza HA, including a vesicular integral membrane protein of 21 kDa (VIP-21) caveolin (Kurzchalia et al., 1992) and VIP-36 (Fiedler et al., 1994) . These are novel proteins that have not previously been identified in other membrane-trafficking pathways. Although these proteins are also present in the basolateral vesicles, it needs to be established whether they are functionally involved in both or only in the apical pathway. One of the components specific to the basolateral vesicles and the basolateral plasma membrane domain is the small GTP-binding protein of the Ras superfamily, Rab8 (Huber et al., 1993) . This protein is closely related to Sec4p, a Saccharomyces cerevisiae protein belonging to the same family and functioning in Golgi-to-plasma membrane transport, and to Ypt2p in Schizosaccharomyces pombe. Interestingly, a cDNA encoding Rab8 can complement a defective YPT2 gene (Craighead et al., 1993) ; the latter gene can in turn complement defective SEC4 in S. cerevisiae (Haubruck et al., 1990) . These similarities suggest that the route from the yeast Golgi complex to the cell surface is equivalent to the basolateral pathway in MDCK cells.
In this study we have analyzed whether the NSF-SNAP-SNARE machinery known to be involved in eukaryotic vesicular docking and fusion events participates in vesicular trafficking from the TGN to the apical and basolateral plasma membrane in MDCK cells. The involvement of these proteins is well documented in ER-to-Golgi transport in various cell types (Ferro-Novick and Jahn, 1994) . We used this pathway as an internal control when testing the effects of the anti-NSF antibodies and a-SNAP protein on post-Golgi traffic in SLO-permeabilized MDCK cells. We found that basolateral transport was inhibited by the anti-NSF antibodies and stimulated by the addition of a-SNAP as efficiently as ER-to-Golgi transport. These results provide strong evidence for the involvement of NSF and SNAPS in the TGN-to-basolateral plasma membrane transport in MDCK cells. The inhibition of basolateral transport by both TeTx and BoNT F further confirms this conclusion and suggests the presence of SNARES in the basolateral transport vesicles and in the acceptor plasma membrane domain. We also found that Rab-GDI inhibited basolateral transport, as expected from the previously documented Rab8 involvement. Thus, members of at least two protein families generally implicated in providing specificity to membrane docking and fusion, SNARES and Rabs, seem to function in the basolateral pathway in addition to the common factors, NSF and SNAPS.
In the transport assay measuring delivery of HA to the apical surface, none of the NSF monoclonal antibodies nor the a-SNAP protein produced any effect. Neither TeTx nor BoNT F inhibited this transport pathway. However, only a positive result, the inhibition of transport, is truly informative in a case in which the SNARE amino acid sequence is unknown. The highly sequence-specific cleavage leaves the possibility that the SNARES in the apical pathway are insensitive to the toxins because the appropriate cleavage sites are missing. A further negative result was that Rab-GDI had no effect on apical transport. The lack of involvement of Rab proteins is supported by our recent finding that the apically enriched small GTP-binding proteins previously identified in the immunoisolated apical vesicles are probably due to contaminants (T. Yoshimori and K. S., unpublished data).
The question therefore remains why the reagents affecting the Rab-NSF-SNAP-SNARE mechanism were without an effect in apical transport. Weconsiderthe twoprincipal factors differing between the apical and basolateral assays, the viral marker protein and the permeabilized cell surface, to be unlikely explanations for the observed differential effects in the two pathways. These two parameters are well controlled in the ER-to-Golgi transport assay in which the effects were similar to those in the basolateral assay, but the virus used and the cell surface chosen to be permeabilized were the same as in the apical assay. Moreover, in testing several other factors affecting both basolateral and apical transport, we have not observed the apical assay to be more insensitive to manipulation (Pimplikar and Simons, 1993; Lafont et al., 1994; Pimplikar et al., 1994; Fiedler et al., 1995) .
It is possible that the apical transport pathway relies on NSF and SNAPS, which function as the corresponding molecules in the ER-to-Golgi and the basolateral route, but differ structurally so that our probes do not distinguish them. In this case, the proteins would have apical isoforms. None of the anti-NSF antibodies would recognize the apical NSF, and the exogenously added a-SNAP would be too different from the apical a-SNAP to replace it functionally. Yet another alternative is that although the added a-SNAP can be utilized in the transport reaction, another component is rate limiting, masking the stimulatory effect of a-SNAP. Since a-SNAP is known to have its brain-specific p isoform, it is alsoconceivable that NSF has closely related homologs. The existence of NSF isoforms might also explain why the expression levels of this generally used molecule vary considerably among tissues, as detected by NSF antibody immunoreactivity (Hong et al., 1994) . Distantly related homologs of NSF have been described that possess NEM-inhibitable ATPase activity and may also participate in fusion reactions (Koller and Brownstein, 1987; Peters et al., 1990; Frohlich et al., 1991) .
Another possible explanation for the insensitivity of apical transport to the reagents tested is that a Rab-NSF-SNAP-SNARE-independent mechanism mediates vesicle docking and fusion. If there is such a mechanism, what molecules could mediate docking and fusion to the apical membrane? As discussed above, those MDCK proteins that are incorporated into the TGN-derived vesicles, but do not belong to the transportable cargo, are obvious candidates for the vesicular targeting and fusion machinery. In view of the putative differences between the apical and basolateral docking and fusion mechanisms, the most attractive proteins would be those found preferentially or exclusively in apical vesicles. The cDNA encoding the protein with the highest enrichment in apical vesicles has recently been cloned, and the sequence predicts a protein belonging to a large family of Ca-sensitive phospholipidbinding proteins, annexins, that have been implicated in several membrane trafficking events (Creutz, 1992) . This recently described member of the family, designated annexin 13b, is peripherally associated with the cytoplasmic side of the vesicle membranes and enriched beneath the apical plasma membrane (Fiedler et al., 1995) . It has a restricted tissue distribution being expressed only in kidney and intestine. Functional importance of this protein for apical transport in MDCK cells is suggested by specific inhibition of apical, but not basolateral, transport by specific anti-annexin 13b antibodies (Fiedler et al., 1995) . Interestingly, other members of the annexin family have been reported to mediate membrane-membrane interactions leading to exocytosis and to induce secretory vesicle fusion (Creutz, 1992) . More work will be needed to define the docking and fusion machinery of apical vesicles in MDCK cells and to establish whether annexin 13b plays a specific role or not. The a-SNAP cDNA in POE-9 vector was provided by T. Sdllner and J. Rothman (Rockefeller Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York). Hiss-tagged a-SNAP was expressed in Escherichia coli and purified on a Ni-NTA-agarose column (Qiagen, Chatsworth, CA) as described previously . Hiss-tagged NSF was purified according to the method of Tagaya et al. (1993) and HisBtagged Rab-GDI according lo the method of Ullrich et al. (1995 Cell Culture and Viral Infections MDCK strain II cells were grown on 1.2 cm Transwell filters (3401), as described previously (Pimplikar et al., 1994) , wiq plating on 2.5 x lo5 cells per filter. The filter cultures were maintained at 37OC in 5% CO* for 3-4 days, during which time the medium was changed once or twice. The viral strains and the infection procedures used were exactly as detailed by Pimplikar et al. (1994) .
In Vitro Transport of VSV G and HA in Permeabilized
MDCK Cells
The pulse labeling and chase of viral proteins, SLO titration and activation, cell permeabilization, cytosol depletion, and reconstitution of transport in all three pathways were carried out according to the methods of Pimplikar et al. (1994) with the following modifications.
Because of the smaller size of the filters used, all incubations previously done in 400 PI of solution apically and 100 ~1 basolaterally (for 2.4 cm diameter filters) were now carried out in 100 ~1 of solution apically and 25 PI basolaterally.
Incubations for which the volumes had been 1 ml of solution apically and 2-2.6 ml basolaterally were now carried out in 0.7 ml and 1.5 ml of solution, respectively.
The amount of ["Slmethionine was reduced lo 12 pcilfilter.
Additionally, in the TGN-to-apical surface transport, the 6 min chase at 37OC after the pulse was omitted, and in the ER-to-Golgi transport, the pulse was shortened from 10 to 5 min to decrease the amount of HA reaching the acceptor domain in a cytosol-independent manner. In all the ER-to-Golgi transport assays, the basolateral cell surface was permeabilized.
After the transport, the cells were lysed, proteins were separated by SDS-PAGE, and band intensities were quantitated using Phosphorlmager and Image&ant sofhvare (Molecular Dynamics, Sunnyvale, CA) according to the method of Pimplikar et al. (1994) . The amount of VSV G or HA transported was calculated as described previously (Pimplikar et al., 1994 ) (percentage of HA on the cell surface = 2 x HA2/HA + 2 x HA2; percentage of VSV G on the cell surface = surface immunoprecipitated VSV G/total VSV G; percentage of HA reaching Golgi complex = endo H-resistant HA/end0 H-resistant + endo H-sensitive HA). The values are expressed as control cytosol-dependent transport being 100% (transport in the presence of exogenously added cytosol minus transport in the absence of added cytosol). HeLa cytosol, prepared as described previously (Pimplikar et al., 1994) , was used in all assays. Upon cyiosol addition. the apical transport is increased about 3-fold (3.0 f 0.6; n = 25), basolateral transport P-fold (1.9 f 0.4; n = 25), and ER-to-Golgi transport 4-fold (4.1 f 0.7; n = 25). All transport assays were performed with duplicate filters, and the number of experiments performed per each condition tested is indicated in the figure legends. In transport assays in which endogenous cytosol was not depleted, after binding and washing away excess SLO at 4OC, transport was reconstituted by transferring the filters directly to 37OC in the presence of an ATP-regenerating system (1 mM ATP, 6 mM creatine phosphate, and 50 uglml creatine kinase) and transport buffer (115 mM potassium acetate, 25 mM HEPES-KOH [pH 7.4],2.5 mM MgCI,, 1 mM dithiothreitol, 5 mM EGTA, 2.5 mM CaC03). Transport is expressed as control temperature-dependent transport being 100% (transport at 37"C minus transport at 4OC). Both apical and basolateral transport are stimulated about 4-fold (4.2 f 0.8; n = 10) upon shift to 37oc.
Addition
of Anti-NSF Antibodies, a-SNAP, Rab-GDI, and Clostridial Neurotoxins to the Transport Assays Antibody 2E5,6E6, or 2C8 was added to the exogenous cytosol (one tenth of total volume, which is the maximal cylosol dilution not interfering with transport efficiency; final antibody concentrations, 25-48 ugl ml, 24 &ml, and 49 ug/ml, respectively) and incubated 3-4 hr on ice before addition to the cytosol-depleted cells. The cells were further incubated 30 min at 4OC with the cytosol-containing antibody before starting the transport at 37OC. To the control cytosol transport buffer or an irrelevant antibody (serum IgG; final concentration, 50 pglml) was added one tenth of total volume. To overcome the antibody inhibition, 2E5 was incubated 2 hr on ice with Hiss-tagged NSF, after which exogenous cytosol was added and the mixture incubated 3 hr on ice before addition to the cytosoldepleted cells. The cells were further incubated 30 min at 4OC before starting transport. The final concentration of 2E5 was 25 uglml (which produced equally efficient inhibition as 48 uglml) and that of His-tagged NSF was 40 uglml. His-tagged NSF was first dialyzed against KOAc buffer (115 mM potassium acetate, 25 mM HEPES-KOH [pH 7.41, 2.5 mM MgCl& since the NSF storage buffer inhibited transport.
The recombinant a-SNAP protein (eluate from Ni-NTA-agarose column, 30 mglml) was dialyzed against KOAc buffer, diluted in the same buffer, and added to the exogenous cytosol without occupying more than one tenth of total volume. The control cytosol was diluted similarly with KOAc buffer. The recombinant His-tagged Rab-GDI (13 mglml in 20 mM HEPES-KOH [pH 7.21, 10 mM 8-mercaptoethanol) was added to both the cytosol depletion buffer and the exogenous cytosol, and the control samples were diluted similarly with GDI storage buffer. The active TeTx L chain (1.54 mg/ml) was stored at -70°C and thawed immediately prior to usage. BoNT F (1.34 mglml) was stored in the dichain form at -70°C and activated by 30 min incubation at 37'C in the presence of 10 mM dithiothreitol before usage. In the experiments in which cytosol was depleted, TeTx or BoNT F was added both to the transport buffer during cytosol depletion and to the exogenously added cytosol. The control cytosol was diluted accordingly with KOAc buffer. The cells were incubated 15-20 min at 4°C before transport at 37OC. When cytosol was not depleted, the active toxin was added to the transport buffer and the cells transferred directly to 37OC.
Western
Blot Analysis To test theconcentrationsof clostridial neurotoxinsneededfor efficient cleavage of VAMP homologs in SLO-permeabilized MDCK cells, we cultured cells on 1.2 cm diameter filters exactly as for the transport assay. SLO (same concentrations as in the transport assay) was bound at 4OC on either the apical or basolateral surface. After washing, excess SLO cells were incubated at 20°C for 30 min and for increasing times at 37OC in the presence of increasing concentrations of the toxins on the permeabilized side. The toxins were diluted in 100 ul of transport buffer apically and in 25 ul basolaterally.
Immediately after the incubation, the cells were lysed in 0.2% SDS, 2% NP-40 and protease inhibitor cocktail (chymostatin, leupeptin, antipain, and pepstatin A; final concentration of 25 &ml each). Aliquots of each condition were separated on 17% reducing SDS-polyacrylamide gels, and proteins were transferred to nitrocellulose membrane in a blotting buffer consisting of 25 mM Tris, 190 mM glycine, and 20% methanol. Unspecific antibody binding was blocked by incubating the filter in 5% nonfat dried milk, 0.1% Tween 20 in phosphate-buffered saline; the filter was then incubated with the primary antibody (anti-VAMP-2 or anti-PDI) diluted in blocking solution, and the staining was visualized using an HRP-conjugated secondary antibody and ECL detection system. For measuring the removal of Rab5 by Rab-GDI, filter-grown cells were permeabilized with SLO apically or basolaterally exactly as in the transport assays. Rab-GDI was added apically or basolaterally, as during the transport assays, for 30 min at 20°C in the transport buffer and for 50 min at 37°C in the presence of exogenous cytosol. The cells were then washed extensively for 1.5 hr at 4°C with phosphate-buffered saline containing 0.9 mM CaCl* and 0.5 mM MgCb on both apical and basolateral sides to remove the Rabs extracted from membranes.
The cells were lysed in SDS-PAGE sample buffer, and aliquots were separated on 13% reducing SDS-polyacrylamide gels. Western blotting and detection were as described above, using antiRab5 primary antibody. The intensities of the bands were quantitated using densitometry.
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